{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:46:18Z","timestamp":1765547178938,"version":"3.41.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Takeda Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The goal of the study was to identify and characterize RNA virus variants containing mutations spread over genomic distances &amp;gt;5\u2009kb. As proof of concept, high-quality viral RNA of the Dengue 2 component of Takeda\u2019s tetravalent dengue vaccine candidate (TDV-2) was used to develop a reverse transcription\u2013polymerase chain reaction protocol to amplify a \u223c5.3\u2009kb cDNA segment that contains the three genetic determinants of TDV-2 attenuation. Unique molecular identifiers were incorporated into each viral cDNA molecule for PacBio library preparation to improve the quantitative precision of the observed variants at the attenuation loci. Following assay optimization, PacBio long-read sequencing was validated with multiple clone-derived TDV-2 revertant variants and four complex revertant mixtures containing various compositions of TDV-2 and revertant viruses. PacBio sequencing analysis correctly identified and quantified variant composition in all tested samples, demonstrating that TDV-2 revertants could be identified and characterized and supporting the use of this method in the differentiation and quantification of complex variants of other RNA viruses. Long-read sequencing can identify complex RNA virus variants containing multiple mutations on a single-genome molecule, which is useful for in-depth genetic stability and revertant detection of live-attenuated viral vaccines, as well as research in virus evolution to reveal mechanisms of immune evasion and host cell adaption.<\/jats:p>","DOI":"10.1093\/biomethods\/bpae004","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T05:15:26Z","timestamp":1707023726000},"source":"Crossref","is-referenced-by-count":1,"title":["Identification and quantitation of multiple variants in RNA virus genomes"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-8739","authenticated-orcid":false,"given":"Johnny","family":"Sena","sequence":"first","affiliation":[{"name":"National Center for Genome Resources , Santa Fe, NM, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4486-220X","authenticated-orcid":false,"given":"Lovkesh","family":"Karwal","sequence":"additional","affiliation":[{"name":"Vaccine Business Unit, Takeda Pharmaceuticals , Cambridge, MA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callum","family":"Bell","sequence":"additional","affiliation":[{"name":"National Center for Genome Resources , Santa Fe, NM, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Devitt","sequence":"additional","affiliation":[{"name":"National Center for Genome Resources , Santa Fe, NM, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye","family":"Schilkey","sequence":"additional","affiliation":[{"name":"National Center for Genome Resources , Santa Fe, NM, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Huang","sequence":"additional","affiliation":[{"name":"Arboviral Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention , Fort Collins, CO, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Livengood","sequence":"additional","affiliation":[{"name":"Vaccine Business Unit, Takeda Pharmaceuticals , Cambridge, MA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash","family":"Das","sequence":"additional","affiliation":[{"name":"Vaccine Business Unit, Takeda Pharmaceuticals , Cambridge, MA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansi J","family":"Dean","sequence":"additional","affiliation":[{"name":"Vaccine Business Unit, Takeda Pharmaceuticals , Cambridge, MA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"key":"2024022714153248900_bpae004-B1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ilar\/ilx026","article-title":"Are RNA viruses candidate agents for the next global pandemic? A review","volume":"58","author":"Carrasco-Hernandez","year":"2017","journal-title":"ILAR J"},{"key":"2024022714153248900_bpae004-B2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-642-20718-1_14","article-title":"Viruses with single-stranded, positive-sense RNA genomes","volume":"12","author":"Modrow","year":"2013","journal-title":"Mol Virol"},{"key":"2024022714153248900_bpae004-B3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-803109-4.00010-6","article-title":"Introduction to RNA viruses","volume-title":"Viruses","author":"Payne","year":"2017"},{"key":"2024022714153248900_bpae004-B4"},{"key":"2024022714153248900_bpae004-B5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"key":"2024022714153248900_bpae004-B6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(20)30556-0","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial","volume":"395","author":"Tricou","year":"2020","journal-title":"Lancet"},{"key":"2024022714153248900_bpae004-B7","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"key":"2024022714153248900_bpae004-B8","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.74.7.3011-3019.2000","article-title":"Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3","volume":"74","author":"Butrapet","year":"2000","journal-title":"J Virol"},{"key":"2024022714153248900_bpae004-B9","doi-asserted-by":"crossref","first-page":"e2243","DOI":"10.1371\/journal.pntd.0002243","article-title":"Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax)","volume":"7","author":"Huang","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2024022714153248900_bpae004-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2005.06.019","article-title":"Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA","volume":"131","author":"Butrapet","year":"2006","journal-title":"J Virol Methods"},{"key":"2024022714153248900_bpae004-B11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/vbz.2010.0150","article-title":"Replication of the primary dog kidney-53 dengue 2 virus vaccine candidate in Aedes aegypti is modulated by a mutation in the 5' untranslated region and amino acid substitutions in nonstructural proteins 1 and 3","volume":"11","author":"Brault","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2024022714153248900_bpae004-B12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/v12101187","article-title":"A systematic evaluation of high-throughput sequencing approaches to identify low-frequency single nucleotide variants in viral populations","volume":"12","author":"King","year":"2020","journal-title":"Viruses"},{"key":"2024022714153248900_bpae004-B13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gpb.2015.08.002","article-title":"PacBio sequencing and its applications","volume":"13","author":"Rhoads","year":"2015","journal-title":"Genom Proteom Bioinform"},{"key":"2024022714153248900_bpae004-B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fimmu.2014.00263","article-title":"A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates","volume":"5","author":"Ambuel","year":"2014","journal-title":"Front Immunol"},{"key":"2024022714153248900_bpae004-B15","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2024022714153248900_bpae004-B16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"2024022714153248900_bpae004-B17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/bioinformatics\/bts091","article-title":"Unipro UGENE: a unified bioinformatics toolkit","volume":"28","author":"Okonechnikov","year":"2012","journal-title":"Bioinformatics"},{"key":"2024022714153248900_bpae004-B18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2024022714153248900_bpae004-B19","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","article-title":"Detection of ultra-rare mutations by next-generation sequencing","volume":"109","author":"Schmitt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024022714153248900_bpae004-B20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41592-020-01041-y","article-title":"High-accuracy long-read amplicon sequences using unique molecular identifiers with Nanopore or PacBio sequencing","volume":"18","author":"Karst","year":"2021","journal-title":"Nat Methods"},{"key":"2024022714153248900_bpae004-B21"},{"key":"2024022714153248900_bpae004-B22","doi-asserted-by":"crossref","first-page":"e3938","DOI":"10.21769\/BioProtoc.3938","article-title":"Primer ID next-generation sequencing for the analysis of a broad spectrum antiviral induced transition mutations and errors rates in a coronavirus genome","volume":"11","author":"Zhou","year":"2021","journal-title":"Bio Protoc"},{"key":"2024022714153248900_bpae004-B23","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/nar\/gkq543","article-title":"A flexible and efficient template format for circular consensus sequencing and SNP detection","volume":"38","author":"Travers","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2024022714153248900_bpae004-B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2164-13-375","article-title":"Pacific biosciences sequencing technology for genotyping and variation discovery in human data","volume":"13","author":"Carneiro","year":"2012","journal-title":"BMC Genomics"},{"key":"2024022714153248900_bpae004-B25","doi-asserted-by":"crossref","first-page":"e1009431","DOI":"10.1371\/journal.ppat.1009431","article-title":"High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19","volume":"17","author":"Ko","year":"2021","journal-title":"PLoS Pathog"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpae004\/56580346\/bpae004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/9\/1\/bpae004\/56761451\/bpae004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/9\/1\/bpae004\/56761451\/bpae004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T14:31:42Z","timestamp":1709044302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpae004\/7600430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,11]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpae004","relation":{},"ISSN":["2396-8923"],"issn-type":[{"type":"electronic","value":"2396-8923"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2024,1,1]]},"article-number":"bpae004"}}